1990
DOI: 10.1016/s0021-9258(19)39565-1
|View full text |Cite
|
Sign up to set email alerts
|

KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
37
0

Year Published

1996
1996
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 589 publications
(37 citation statements)
references
References 36 publications
0
37
0
Order By: Relevance
“…In order to investigate a role for CamK in the regulation of BDNF mRNA in vivo, we have examined the effect of 1-[N,O-bis(5isoquinoline-sulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN-62) treatment prior to kainic acid-induced seizures. KN-62 has been reported to specifically inhibit CamKII and IV activity (Tokumitsu et al, 1990;Enslen & Soderling, 1994). Our results suggest that multiple pathways exist for the induction of BDNF mRNA in vivo at least some of which are mediated in a CamKII/IV-dependent manner.…”
Section: Introductionmentioning
confidence: 57%
“…In order to investigate a role for CamK in the regulation of BDNF mRNA in vivo, we have examined the effect of 1-[N,O-bis(5isoquinoline-sulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN-62) treatment prior to kainic acid-induced seizures. KN-62 has been reported to specifically inhibit CamKII and IV activity (Tokumitsu et al, 1990;Enslen & Soderling, 1994). Our results suggest that multiple pathways exist for the induction of BDNF mRNA in vivo at least some of which are mediated in a CamKII/IV-dependent manner.…”
Section: Introductionmentioning
confidence: 57%
“…CaMKII regulates transmitter metabolism in sympathetic neurons (Cahill and Perlman, 1987), and PKC contributes to internalization and desensitization of muscarinic receptors (Liles et al, 1986); hence both are candidates. Treatment of recipient neuroblastoma cells with KN-62, a specific membranepermeant inhibitor of CaMKII (Tokumitsu et al, 1990), prevented the appearance of LTS (n ϭ 4) but did not inhibit the rise in cGMP with muscarinic stimulation (Fig. 7A).…”
Section: How Is Lts Maintained?mentioning
confidence: 97%
“…To address whether CaM kinase may mediate the effects of CaM on PLC␤ activity, 1321N1 cells were treated with CaMKII inhibitors, 30 M KN-93 or 2 M KN-62 (26,27). In 1321N1 cells pre-treated with CaMKII inhibitors for 30 min, there was no effect on basal or carbachol-stimulated IP hydrolysis (Fig.…”
Section: Table I Specific Interaction Of Plc␤ 3 With Cammentioning
confidence: 99%